|
⚲
|
| Keyboard |
| Bassler Bonnie L
✚
|
|
|---|---|
| CIK # | 0001683607 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001683607] | |
| 4 | [0001683607] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Royalty Pharma PLC | |
| Bassler Bonnie L | |
| Regeneron Pharmaceuticals Inc | |
| K2 Therapeutics Inc | |
| Kaleido Biosciences Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Royalty Pharma PLC RPRX
Class A Ordinary Shares
|
2026-03-31 | Grant | 815 | $45.98 | 37,474 |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2026-01-07 | Option exercise | 1,500 | $374.12 | 561,180 |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2026-01-07 | Sell | 1,500 | $800.00 | 1,200,000 |
|
K2 Therapeutics Inc CDTX
Common Stock
|
2026-01-07 | Disposed to issuer | 15 | $221.50 | 3,322 |
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2026-01-07 | Disposed to issuer | 1,750 | ||
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2026-01-07 | Disposed to issuer | 2,125 | ||
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2026-01-07 | Disposed to issuer | 2,125 | ||
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2026-01-07 | Disposed to issuer | 1,400 | ||
|
Regeneron Pharmaceuticals Inc REGN
Non-Qualified Stock Option (right to buy) · derivative
|
2026-01-07 | Option exercise | 1,500 | $0.00 | |
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2026-01-07 | Disposed to issuer | 875 | ||
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2026-01-07 | Disposed to issuer | 11,100 | ||
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2026-01-07 | Disposed to issuer | 16,000 | ||
|
Regeneron Pharmaceuticals Inc REGN
Non-Qualified Stock Option (right to buy) · derivative
|
2026-01-02 | Grant | 1,962 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2026-01-02 | Grant | 155 | $0.00 | |
|
Royalty Pharma PLC RPRX
Class A Ordinary Shares
|
2025-12-31 | Grant | 967 | $38.74 | 37,462 |
|
Regeneron Pharmaceuticals Inc REGN
Non-Qualified Stock Option (right to buy) · derivative
|
2025-11-20 | Option exercise | 760 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2025-11-20 | Sell | 760 | $750.00 | 570,000 |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2025-11-20 | Option exercise | 760 | $371.40 | 282,264 |
|
Royalty Pharma PLC RPRX
Class A Ordinary Shares
|
2025-06-30 | Grant | 1,064 | $35.24 | 37,495 |
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2025-06-18 | Grant | 11,100 | $0.00 | |
| showing 20 of 141 most recent transactions | |||||